| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Siponimod impurity 1 |
辛波莫德杂质1 |
40180-80-1 |
详细
|
| Siponimod impurity 2 |
辛波莫德杂质2 |
|
详细
|
| Ticagrelor Impurity |
替格瑞洛杂质 |
220241-60-1 |
详细
|
| Ticagrelor ImpurityC |
替格瑞洛杂质C |
2165881-71-8 |
详细
|
| Voriconazole Impurity |
伏立康唑杂质 |
1307315-02-1 |
详细
|
| Voriconazole Impurity |
樟脑磺异丙酯 |
2094735-34-7 |
详细
|
| Voxelotor(GBT440, GTX011) |
沃塞洛托 |
1446321-46-5 |
详细
|
| 5-nitroisophthaldiamide |
5-硝基苯-1,3-二甲酰胺 |
38177-07-0 |
详细
|
| Tomoxetine-n-amide impurity |
托莫西汀-N-酰胺杂质 |
|
详细
|
| N-Desmethyl Clarithromycin |
克拉霉素杂质D |
101666-68-6 |
详细
|
| Famotidine Related Compound A Hydrochloride |
法莫替丁杂质 |
76833-47-1 |
详细
|
| H-ASN-OME HCL |
L-天冬酰胺甲酯盐酸盐 |
57461-34-4 |
详细
|
| rac-N-(2,3-Dihydroxypropyl)-5-nitroisophthalamic acid |
5-硝基异钛酸-(2,3-二羟基丙基)-酰胺甲酸 |
122731-58-2 |
详细
|
| 5-AMINO-N-(2,3-DIHYDROXY-1-PROPYL)-ISOPHTHALAMIDE HYDROCHLORIDE |
|
122731-74-2 |
详细
|
| ROC-325 |
ROC-325 |
1859141-26-6 |
详细
|
| 5-Pyrimidinecarboxamide, 2-[5-[(3-ethoxy-2-pyridinyl)oxy]-3-pyridinyl]-N-[(3S)-tetrahydro-3-furanyl]- |
(S) -2-(5-((3-乙氧基吡啶-2-基]氧基]吡啶-3-基)-N-(四氢呋喃-3-基)嘧啶-5-甲酰胺 |
2186700-33-2 |
详细
|
| Benzeneacetamide, N-(2,4-difluorophenyl)-4-[[2-[4-(ethylsulfonyl)phenyl]acetyl]amino]-2-fluoro-α,α-dimethyl- |
Benzeneacetamide, N-(2,4-difluorophenyl)-4-[[2-[4-(ethylsulfonyl)phenyl]acetyl]amino]-2-fluoro-α,α-dimethyl- |
2068119-11-7 |
详细
|
| BAY 1316957) |
BAY-1316957 |
1613264-40-6 |
详细
|
| Urea, N-(4-chloro-3-nitrophenyl)-N'-(4-fluorophenyl)- |
Urea, N-(4-chloro-3-nitrophenyl)-N'-(4-fluorophenyl)- |
897326-30-6 |
详细
|
| Eprrazole sodium impurity I |
艾普拉唑钠杂质I |
|
详细
|
| Eprrazole sodium impurity P |
艾普拉唑钠杂质P |
|
详细
|
| Eprrazole sodium impurity SM2Z2 |
艾普拉唑钠杂质SM2Z2 |
|
详细
|
| Eprrazole sodium impurity SM1Z5 |
艾普拉唑钠杂质SM1Z5 |
|
详细
|
| 6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine |
6-(4-甲基-1-哌嗪基)-N-(5-甲基-1H-吡唑-3-基)-2-[(1E)-2-苯乙烯基]-4-嘧啶胺 |
934353-76-1 |
详细
|
| ML349 |
APT-2抑制剂 |
890819-86-0 |
详细
|